Exosomes – tiny biological nanoparticles which transfer information between cells – offer significant potential in detecting and treating disease, the most comprehensive overview so far of research in the field has concluded.
Areas which could benefit include cancer treatment and regenerative medicine, say Dr Steven Conlan from Swansea University, Dr Mauro Ferrari of Houston Methodist Research Institute in Texas, and Dr Inês Mendes Pinto from the International Iberian Nanotechnology Laboratory in Portugal. Their commissioned paper, Exosomes as Reconfigurable Therapeutic Systems, is published today by Cell Press in Trends in Molecular Medicine.
Exosomes are particles produced by all cells in the body and are from 30-130 nanometres in size – a nanometre is one-billionth of a metre. They act as biological signalling systems, communicating between cells, carrying proteins, lipids, DNA and RNA. They drive biological processes, from modulating gene expression to transmitting information through breast milk.
Though discovered in 1983, the full potential of exosomes is only gradually being revealed. The researchers show that the nanoparticles’ possible medical benefits fall into three broad categories:
- Detecting disease – by acting as disease-specific biomarkers
- Activating immune responses to boost immunity
- Treating diseases – serving as the vehicle for drugs, for example bearing cancer therapies as their payload, to target tumours
One of the most useful properties of exosomes is that they are able to cross barriers such as the plasma membrane of cells, or the blood/brain barrier. This makes them well-suited to delivering therapeutic molecules in a very targeted way.
The potential benefits of exosomes can be seen in the wide range of research projects – cited in the paper – already either completed or under way, in areas such as:
- Improved testing for prostate cancer
- A small-cell lung cancer trial
- Stem cell-derived exosomes strengthening heart muscles
- Regeneration of muscle and tissue
- Parkinson’s
- Diabetes
The team caution that there is more to do before research into exosomes translates into new techniques and treatments. Side-effects need to be considered, and a standardised approach to isolating, characterising and storing exosomes will need to be developed.
Researchers will also need to ensure that the properties of exosomes do not end up causing harm: for example they can transfer drug resistance and pacify the immune system.
Nevertheless, the potential is very clear, with the team describing exosomes as “increasingly promising”.
Professor Steve Conlan of Swansea University Medical School, one of the authors of the paper, said:
“Our survey of research into exosomes shows clearly that they offer enormous potential as a basis for detecting and treating disease.
Further studies are necessary to turn this research into clinical outcomes, but researchers and funders should be very encouraged by our findings. Our own research in Swansea is investigating the use of exosomes and exosome-like synthetic nanoparticles in combatting ovarian and endometrial cancer.
Progress in this field depends on partnership. As the authorship of our own paper illustrates, researchers in different countries are increasingly working together in nanohealth. Swansea University has wider links with Houston and Portuguese based researchers in the field.
It’s also important to build partnerships outside academia, in particular with government and companies in this fast-growing sector.”
Learn more:Tiny nanoparticles offer significant potential in detecting and treating disease – new review
The Latest on: Exosomes
[google_news title=”” keyword=”exosomes” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- EBRD Launches €25 Million Digital Transformation Loan Initiative for Türk Ekonomi Bankasıon May 2, 2024 at 2:58 am
The European Bank for Reconstruction and Development (EBRD) has initiated a groundbreaking Digital Transformation Financing Facility (DTFF) with ...
- Rarebreed Dining Partners with Savills for Strategic Property Evaluationon May 2, 2024 at 2:48 am
Rarebreed Dining, known for its steak-focused pubs including The Plough Inn, Cobham, and The Shurlock Inn, Twyford, has enlisted international re ...
- The Science of Beauty: How Bleeding-Edge Biotech Is Transforming How We Lookon May 1, 2024 at 8:00 am
From skin care to fragrance, the best grooming products on the market are now informed by years—and sometimes decades—of lab-grade research.
- Elevai Labs in deal to develop co-treatments for weight-loss drugson May 1, 2024 at 6:38 am
Elevai is a 2019 startup working on advanced stem cell exosome technology for post-procedure aesthetic skin care patients. Exosomes are components of cell vesicles that contain nucleic acids, proteins ...
- Why Coya Therapeutics Is A Smart Speculative Buy For Neurodegenerative Diseaseson May 1, 2024 at 3:45 am
Coya Therapeutics is a biotech company developing therapies for neurodegenerative diseases. Read why I deem COYA stock as a good speculative buy.
- Cell Therapy Manufacturing: Time to Move Faston April 30, 2024 at 9:54 am
The more quickly manufacturing and release obstructions can be cleared, the sooner lifesaving treatments can be administered.
- ZTX Becomes Payment Option for Real World Medical Services In Japanon April 30, 2024 at 7:18 am
ZTX, the Web3 social metaverse platform, is partnering with Frontier, a leading Japanese operator and distributor of regenerative medicine, to offer its native ZTX token as a payment method for ...
- BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technologyon April 30, 2024 at 4:30 am
Leading regenerative medicine and aesthetics innovators collaborate to build a vertically integrated, best-in-class biocosmeceutical platform — — Exclusive, five (5)-year agreement includes ...
- Researchers develop tiny droplets that harness laser light to detect disease markerson April 29, 2024 at 7:19 am
A team of researchers led by Nanyang Technological University, Singapore (NTU Singapore) has created tiny droplets that, when activated by laser light, can detect viral protein biomarkers indicating ...
- SickScience Tackles Hair Growth With Second Producton April 28, 2024 at 9:01 pm
Just seven weeks after launching, SickScience is already tackling a new category - hair. The biotech brand has harnessed its hero ingredient, NX35 Growth Technology, in addition to garlic and wheat ...
via Google News and Bing News